title: Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population.
abstract: Recent evidence suggested that prostate cancer stem/progenitor cells (CSC) are responsible for cancer initiation as well as disease progression. Unfortunately, conventional therapies are only effective in targeting the more differentiated cancer cells and spare the CSCs. Here, we report that PSP, an active component extracted from the mushroom Turkey tail (also known as Coriolus versicolor), is effective in targeting prostate CSCs. We found that treatment of the prostate cancer cell line PC-3 with PSP led to the down-regulation of CSC markers (CD133 and CD44) in a time and dose-dependent manner. Meanwhile, PSP treatment not only suppressed the ability of PC-3 cells to form prostaspheres under non-adherent culture conditions, but also inhibited their tumorigenicity in vivo, further proving that PSP can suppress prostate CSC properties. To investigate if the anti-CSC effect of PSP may lead to prostate cancer chemoprevention, transgenic mice (TgMAP) that spontaneously develop prostate tumors were orally fed with PSP for 20 weeks. Whereas 100% of the mice that fed with water only developed prostate tumors at the end of experiment, no tumors could be found in any of the mice fed with PSP, suggesting that PSP treatment can completely inhibit prostate tumor formation. Our results not only demonstrated the intriguing anti-CSC effect of PSP, but also revealed, for the first time, the surprising chemopreventive property of oral PSP consumption against prostate cancer.
authors: Department of Anatomy, The University of Hong Kong, Hong Kong, Hong Kong SAR.
authors: Sze-Ue
authors: SU
authors: Luk
authors: Terence Kin-Wah
authors: TK
authors: Lee
authors: Ji
authors: J
authors: Liu
authors: Davy Tak-Wing
authors: DT
authors: Lee
authors: Yung-Tuen
authors: YT
authors: Chiu
authors: Stephanie
authors: S
authors: Ma
authors: Irene Oi-Lin
authors: IO
authors: Ng
authors: Yong-Chuan
authors: YC
authors: Wong
authors: Franky Leung
authors: FL
authors: Chan
authors: Ming-Tat
authors: MT
authors: Ling
references: Int J Cancer. 2011 May 1;128(9):2182-91
references: 20617516
references: PLoS Biol. 2009 Jun 2;7(6):e1000121
references: 19492080
references: Int J Oncol. 2001 Jan;18(1):81-8
references: 11115542
references: Antioxid Redox Signal. 2008 Mar;10(3):475-510
references: 18154485
references: J Natl Cancer Inst. 1998 Mar 18;90(6):440-6
references: 9521168
references: Anticancer Res. 1991 Mar-Apr;11(2):993-9
references: 2064356
references: Cell Res. 2009 Jun;19(6):683-97
references: 19365403
references: Science. 1992 Mar 27;255(5052):1707-10
references: 1553558
references: Endocr Relat Cancer. 2006 Sep;13(3):751-78
references: 16954429
references: Res Commun Mol Pathol Pharmacol. 1996 May;92(2):140-8
references: 8774067
references: Clin Cancer Res. 2010 Jun 15;16(12):3113-20
references: 20530701
references: Cancer Biol Ther. 2005 Jun;4(6):638-44
references: 15908782
references: Breast Cancer Res. 2008;10(1):R10
references: 18241344
references: Curr Oncol Rep. 2008 Nov;10(6):529-32
references: 18928669
references: Expert Rev Anticancer Ther. 2008 Jul;8(7):1073-9
references: 18588452
references: Cancer Res. 2007 Apr 15;67(8):3560-4
references: 17440065
references: Cancer Biol Ther. 2007 May;6(5):763-8
references: 17592251
references: Gene Ther. 2002 Dec;9(23):1589-99
references: 12424611
references: Nature. 2004 Nov 18;432(7015):396-401
references: 15549107
references: Int J Oncol. 2008 Mar;32(3):689-99
references: 18292947
references: Cancer Res. 2005 Dec 1;65(23):10946-51
references: 16322242
references: Eur Urol. 2005 Sep;48(3):379-85
references: 15961218
references: Nat Rev Cancer. 2008 Oct;8(10):755-68
references: 18784658
references: Cancer Res. 2005 Oct 15;65(20):9328-37
references: 16230395
references: Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):268-73
references: 19116269
references: Am J Chin Med. 2003;31(1):1-9
references: 12723750
references: Expert Opin Biol Ther. 2009 Aug;9(8):1005-16
references: 19545218
references: Cancer Res. 2007 Apr 1;67(7):3153-61
references: 17409422
references: Oncogene. 2005 Feb 24;24(9):1510-24
references: 15674347
references: BMC Cancer. 2008 Mar 24;8:78
references: 18366723
references: Oncogene. 2003 Jul 17;22(29):4498-508
references: 12881706
references: Br J Cancer. 2008 Feb 26;98(4):756-65
references: 18268494
references: Clin Cancer Res. 2007 Mar 15;13(6):1847-56
references: 17363541
references: Oncogene. 2006 Mar 16;25(12):1696-708
references: 16449977
references: Cancer Res. 2008 Mar 15;68(6):1820-5
references: 18339862
references: Gen Pharmacol. 1998 Jan;30(1):1-4
references: 9457474
references: Hepatology. 2011 Jan;53(1):160-70
references: 20979057
references: Annu Rev Med. 2007;58:205-20
references: 16987081